RHYTHM PHARMACEUTICALS, INC. (RYTM) — Institutional Holders, Q2 2026 (page 4)
307 institutional investment managers reported a RYTM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 301 to 307. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
RYTM 13F holders ranked 301–307 of 307
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 301 | Downshift Financial#301 · 2 sh | 2 | $222.00 | — | New |
| 302 | DiNuzzo Private Wealth#302 · 1 sh | 1 | $112.00 | — | -66.7% |
| 303 | MassMutual Private Wealth & , FSB#303 · 1 sh | 1 | $111.00 | — | New |
| 304 | Principia Wealth Advisory#304 · 1 sh | 1 | $111.00 | <0.01% | New |
| 305 | NOMURA ASSET MANAGEMENT LTD#305 · 0 sh | 0 | $0.00 | 0.00% | New |
| 306 | Persistent Asset Partners Ltd#306 · 0 sh | 0 | $0.00 | 0.00% | New |
| 307 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#307 · 64,031 sh | 64,031 | — | — | -2.7% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.